These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 212852)

  • 1. Effects of renal transplantation on hyperlipidemia and high-density lipoprotein cholesterol (HDL).
    Curtis JJ; Galla JH; Woodford SY; Rees ED; Luke RG
    Transplantation; 1978 Nov; 26(5):364-6. PubMed ID: 212852
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of propranolol therapy and proteinuria in the etiology of post renal transplantation hyperlipidemia.
    Jackson JM; Lee HA
    Clin Nephrol; 1982 Aug; 18(2):95-100. PubMed ID: 6754194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities in the composition of serum high density lipoprotein in renal transplant recipients.
    Jung K; Neumann R; Scholz D; Nugel E
    Clin Nephrol; 1982 Apr; 17(4):191-4. PubMed ID: 7042146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of clofibrate on plasma lipids and high-density lipoprotein levels in renal allograft recipients.
    Bagdade JD; Shantharam VV; Sollek M; Albers JJ
    Clin Nephrol; 1979 Aug; 12(2):83-6. PubMed ID: 230927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal lipoprotein (a) and lipid profiles in renal allograft recipients: effects of treatment with pravastatin.
    Lye WC; Hughes K; Leong SO; Tan CC; Lee EJ
    Transplant Proc; 1995 Feb; 27(1):977-8. PubMed ID: 7879252
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerivastatin modulates antiatherogenic properties of high-density lipoproteins in patients with coronary heart disease and hyperlipidemia.
    Ozerova IN; Jeevan DM; Serdyuk AP; Paramonova IV; Akhmedzhanov NM; Metel'skaya VA; Perova NV
    Bull Exp Biol Med; 2000 Oct; 130(10):983-5. PubMed ID: 11177300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient profile and effect of dietary therapy on post-transplant hyperlipidemia.
    Shen SY; Lukens CW; Alongi SV; Sfeir RE; Dagher FJ; Sadler JH
    Kidney Int Suppl; 1983 Dec; 16():S147-52. PubMed ID: 6376913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipids on chronic uraemic and transplantation patients.
    Viikari J; Forsström J
    Ann Clin Res; 1979 Jun; 11(3):113-7. PubMed ID: 227315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid relation ships in dialysis and renal transplant patients.
    Nicholls AJ; Cumming AM; Catto GR; Edward N; Engeset J
    Q J Med; 1981; 50(198):149-60. PubMed ID: 7029600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein profile in dialysis and transplant patients.
    Lau YK; Woo KT; Lim CH
    Singapore Med J; 1985 Apr; 26(2):193-7. PubMed ID: 3898396
    [No Abstract]   [Full Text] [Related]  

  • 12. Relation of cyclosporine blood levels to adverse effects on lipoproteins.
    Kuster GM; Drexel H; Bleisch JA; Rentsch K; Pei P; Binswanger U; Amann FW
    Transplantation; 1994 May; 57(10):1479-83. PubMed ID: 8197611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlipidemia in long-term survivors of pediatric renal transplantation.
    Sharma AK; Myers TA; Hunninghake DB; Matas AJ; Kashtan CE
    Clin Transplant; 1994 Jun; 8(3 Pt 1):252-7. PubMed ID: 8061364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholesterol bound to high density lipoproteins: critical review of the methods of analysis and personal data].
    Orso Giacone G
    Ann Osp Maria Vittoria Torino; 1982; 24(7-12):286-306. PubMed ID: 7137764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hyperlipidemia in a large sample population.
    Bates HM
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S196-200. PubMed ID: 6177956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of cyclosporin and tacrolimus on lipoprotein oxidation after renal transplantation].
    Martínez Castelao A; Ramos R; Serón D; Gil-Vernet S; Fiol C; Gómez-Gerique N; Yzaguirre MT; Hurtado I; Sabaté I; Alsina J; Grinyó JM
    Nefrologia; 2002; 22(4):364-9. PubMed ID: 12369128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.
    Long S; Tian Y; Zhang R; Yang L; Xu Y; Jia L; Fu M
    Clin Chim Acta; 2006 Apr; 366(1-2):316-21. PubMed ID: 16364275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio.
    Granot E
    Hepatology; 1998 Jan; 27(1):175-80. PubMed ID: 9425934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo development of hypercholesterolaemia and increased HDL-cholesterol: apoprotein A-I ratio in patients with chronic renal failure following kidney transplantation.
    Kobayashi N; Okubo M; Marumo F
    Proc Eur Dial Transplant Assoc; 1983; 19():505-9. PubMed ID: 6410382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.